These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 4655751)

  • 21. Studies on tetanus toxin and toxoid. 3. Sedimentation of toxin and derivatives obtained by sulphite and aldehyde treatments.
    Dawson DJ; Nichol LW
    Aust J Biol Sci; 1969 Feb; 22(1):247-55. PubMed ID: 4891122
    [No Abstract]   [Full Text] [Related]  

  • 22. Tetanus toxoid purification: a case study.
    Vancetto MD; de Oliveira JM; Prado SM; Fratelli F; Higashi HG
    Nat Biotechnol; 1997 Aug; 15(8):807-8. PubMed ID: 9255801
    [No Abstract]   [Full Text] [Related]  

  • 23. [Electrophoretic and immunophoretic study of the antigenic composition of crude and purified tetanus toxoid].
    Volgin IuB; Moroz ZIa; Vasil'eva IV
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Oct; 42(10):65-70. PubMed ID: 5871439
    [No Abstract]   [Full Text] [Related]  

  • 24. A rapid and sensitive method for the identity testing of adsorbed tetanus toxoid.
    Gupta RK; Maheshwari SC; Singh H
    J Biol Stand; 1985 Oct; 13(4):355-9. PubMed ID: 4055810
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates.
    Jennings HJ; Lugowski C
    J Immunol; 1981 Sep; 127(3):1011-8. PubMed ID: 6790606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the toxin-binding inhibition (ToBI) test for the estimation of the potency of the tetanus toxoïd component in vaccines.
    van der Gun J; Akkermans A; Hendriksen C; van de Donk H
    Dev Biol Stand; 1996; 86():199-206. PubMed ID: 8785949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tye use of the immunofluorescence adsorption test (IFAT) for titrating tetanus anatoxins.
    Wojtyla B; Lachowicz T; Reiss J; Zyzyński Z
    Arch Immunol Ther Exp (Warsz); 1969; 17(2):194-9. PubMed ID: 4894353
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fractionation of the proteins of tetanus anatoxin by means of Sephadex gel filtration ].
    Efimova NP
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Aug; 44(8):122-3. PubMed ID: 5615848
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of in vivo and in vitro methods for determining unitage of diphtheria antitoxin in adsorbed diphtheria-tetanus (DT) and diphtheria-tetanus-pertussis (DTP) vaccines.
    Shinde YP; Jadhav SS
    Dev Biol Stand; 1996; 86():245-60. PubMed ID: 8785954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on immune response to atoxic fragments of tetanus toxin and its denatured antigen.
    Chiba K
    Kitasato Arch Exp Med; 1982 Dec; 55(3-4):79-118. PubMed ID: 7186080
    [No Abstract]   [Full Text] [Related]  

  • 31. Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay.
    Aggerbeck H; Heron I
    Dev Biol Stand; 1996; 86():297-301. PubMed ID: 8785958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody response to a single tetanus toxoid booster in young women in rural south India.
    Aruldas K; Muliyil JP; Mathai E; Abraham S; Joseph A; Inbamalar U; Aruldas V
    Natl Med J India; 2001; 14(1):22-3. PubMed ID: 11242693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calibration of replacement international standards of diphtheria and tetanus toxoids for use in flocculation test.
    Preneta-Blanc R; Rigsby P; Wilhelmsen ES; Tierney R; Brierley M; Sesardic D
    Biologicals; 2008 Sep; 36(5):315-26. PubMed ID: 18676158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The isolation and study of pure antitoxic antibodies by the immunosorption method.
    Dalin MV; Kotova TS; Mertsalova NU
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):120-6. PubMed ID: 4736206
    [No Abstract]   [Full Text] [Related]  

  • 35. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?
    Scheifele D; Barreto L; Meekison W; Guasparini R; Friesen B
    CMAJ; 1993 Oct; 149(8):1105-12. PubMed ID: 8221449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal immunization with tetanus toxoid and CNF1 as a new mucosal adjuvant protects BALB/c mice against lethal challenge.
    Munro P; Flatau G; Lemichez E
    Vaccine; 2007 Dec; 25(52):8702-6. PubMed ID: 18035455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gene cloning, optimized expression and immunogenicity evaluation of tetanus toxin fragment C].
    Wang MY; Zhang YN; Lei M; Zuo DM; Zhang LY; Chen ZL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):731-5. PubMed ID: 18504192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross reactive anti-tetanus and anti-melittin Fab fragments by phage display after tetanus toxoid immunisation.
    Vogel M; Lai L; Rudolf MP; Curcio-Vonlanthen V; Miescher S; Stadler BM
    Hum Antibodies Hybridomas; 1996; 7(1):11-20. PubMed ID: 8886832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A report on the use of tetanus toxoid in the management of tetanus.
    Tham NB; Chew LS; Gwee AL
    Singapore Med J; 1968 Dec; 9(4):234-9. PubMed ID: 5728858
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current trends in the use of combined serum and vaccine in tetanus prevention].
    Olivo R; Fabio U
    Boll Ist Sieroter Milan; 1980 Nov; 59(5):455-63. PubMed ID: 7248074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.